We’re looking for a few good directors
Published August 11, 2023
For your consideration.
APC News
Bears repeating: Our 15-hour compounding curriculum is LIVE
Published August 11, 2023
Do you have a thorough understanding of the myriad laws, regulations, and standards that govern the practice of pharmacy compounding?
Some decent reporting on compounded semaglutide
Published August 11, 2023
Recent semaglutide coverage that gets (most of) the facts straight.
Call for comments: Alabama BOP proposal
Published August 11, 2023
Affected pharmacies are encouraged to comment.
APC Annual Membership Meeting is September 19
Published August 11, 2023
An official announcement for APC members.
15-hour online compounding program goes LIVE
Published August 4, 2023
It’s essential that you know a set of constantly changing regulations and standards that guide every aspect of how you prepare a compounded medication—not just the what but the why.
Laura Bray is an angel for change
Published August 4, 2023
Laura is one of our speakers at this year’s CCH, joining an esteemed list that includes FDA’s OCQC Director Gail Bormel, and House Energy & Commerce Committee member Diana DeGette (D-CO).
Drug shortage proposal has “long tail” provision for 503Bs
Published August 4, 2023
A much-needed legislative package with regards to drug shortages (and the handling thereof) is being considered.
Your mission: Help emphasize the threat to cBHT
Published August 4, 2023
Your support for this campaign doesn’t stop at watching the TV spot...
APC’s new CE program fills training gap
Published August 1, 2023
What you don’t know can hurt you—and not just you, but the patients you serve.
E&C member DeGette to speak at CCH
Published July 28, 2023
House Energy & Commerce Committee member Congresswoman Diana DeGette (D-CO) will be a featured speaker at this year's Compounders on Capitol Hill.
Live from your TV, it’s APC!
Published July 28, 2023
Together we can build greater support for our campaign to protect access to compounded hormones.
FDA’s Gail Bormel will be at this year’s Compounders on Capitol Hill. You should be there, too.
Published July 27, 2023
This is just another reason (among many!) that you’ll want to attend APC's annual DC fly-in for pharmacy compounders, September 19-20 at Hilton National Mall The Wharf.
FDA’s Gail Bormel to be featured at CCH
Published July 21, 2023
If you could ask the OCQC director just one question, what would it be?
APC to Alabama BOP: Delay USP <800> enforcement
Published July 21, 2023
APC recently sent a comment letter to the AL BOP regarding USP <800>.
Recap: APC’s Wednesday Issues Briefing
Published July 21, 2023
Missed our July 19 issues briefing? Here's a recap...
A message from APC Board Chair Anthony Grzib
Published July 20, 2023
Here's how you can stand up to compounding.
APC’s cBHT story is going live nationwide on PBS (plus other exciting news)
Published July 14, 2023
There's a lot going on right now, and you really need to be in the know.
Best way to advocate for your patients? Attend CCH!
Published July 14, 2023
Meeting with your members of Congress is crucial to assuring continued patient access to the medications you compound.
APC comments on Oregon proposals
Published July 14, 2023
This week, APC sent a comment letter to the Oregon Board of Pharmacy regarding proposed rules that will affect human and veterinary compounding.
We really need to talk: Join our July 19 issues briefing
Published July 7, 2023
We've scheduled an APC member briefing for July 19. It’s a free teleconference aimed at sharing essential information, including the introduction of new programs that can save you money and help you minimize risks.
FDA briefing on 503B guidance draft
Published July 7, 2023
The agency has announced it will be presenting an overview of the guidance, with an opportunity to ask questions, on July 14, 2023.
From Restore Health: discounted on-demand webinars for APC members
Published July 7, 2023
Restore Health Consulting is offering 20-30% savings on eligible on-demand webinars, including quality assurance, quality control, and regulatory compliance.
APC sends customized letters to encourage CCH registration
Published July 7, 2023
APC is sending some members a special request.
Call to action: Ask senators to sign hormone letter
Published June 30, 2023
Please urge your two US senators to add their names to a letter to FDA led by Senators Tammy Baldwin (WI) and Roger Marshall (KS).
FDA issues draft guidance on 503B wholesaling
Published June 30, 2023
This week, FDA published a new draft guidance on the Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Board chooses Austin, Long Beach for Owner Summits
Published June 30, 2023
This week the APC Board of Directors selected locations for the 2026 and 2027 Owner Summits.
CALL TO ACTION: Urge your Senators to sign hormone letter to FDA
Published June 28, 2023
You need to urge them to add their names to a letter to FDA led by Senators Baldwin (WI) and Marshall (KS) urging the agency to base any action on compounded hormones on legitimate science...
We believe you can fly
Published June 28, 2023
Compounders on Capitol Hill, APC’s annual DC fly-in, is September 19-20—just under three months away. But what’s NOT three months away is our early bird registration deadline, coming up July 7.
